Delivery Order SPE2DB22D9316-SPE2DB24FYP31

Award Date 6/3/24
Potential Completion Date 6/25/24
Potential Value $7.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,313.60, is for the delivery of CEREZYME 400 unit vials to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. holds a significant single-award indefinite delivery contract (IDC) with the DLA, valued at up...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a for-profit, woman-owned small business based in Park Ridge, Illinois. The $13,136.00 contract is for the delivery of CEREZYME 400 UNIT VIALS, a pharmaceutical product, with a completion date of February 27, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDV) with DLA, valued up to $4,999,999 through 2025, for a broad range of pharmaceutical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $14,418.03, is for the delivery of 4,568,295,693 units of the pharmaceutical product CEREZYME 400 UNIT VIALS. The contract has a firm fixed price and is set to be completed by May 22, 2025. DMS Pharmaceutical Group Inc. holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business (WOSB) pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with DLA under the...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $14,449.60 firm fixed-price contract is for the supply of CEREZYME 400 unit vials, with an ultimate completion date of October 3, 2024. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
The U.S. Defense Logistics Agency has awarded a firm-fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is valued at $7,881.60 and covers the delivery of CEREZYME 400 unit vials with a completion date of March 14, 2024. This order is part of a larger indefinite delivery contract (IDV) held by DMS Pharmaceutical Group with the Defense Logistics Agency, contract number 4600082013 under the SPE2DB program,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $14,418.03 contract is for the delivery of 4,568,383,013 units of the pharmaceutical product CEREZYME 400 UNIT VIALS, with a completion date of June 3, 2025. DMS Pharmaceutical Group Inc. is an established federal contractor, holding a $499,999,999 Indefinite Delivery Contract (IDC) with DLA under the SPE2DB...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $7,881.60, is for the delivery of 4564944131 - CEREZYME 400 UNIT VIALS to support the recurring medical supply needs of military health facilities. This delivery order is part of a larger indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA,...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has a ceiling value of $14,418.03 and covers the delivery of 4566955475 CEREZYME 400 UNIT VIALS. The award is part of a larger Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA, valued at $499,999,999 and valid through November 2026. This IDC...
This is a $22,471.44 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Cerezyme 400 unit vials, with a performance period through November 26, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue...
  • SPE2DB22D9316
    Indefinite Delivery Contract
  • SPE2DB22D9316-SPE2DB24FYP31
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, to provide 4,564,878,290 units of CEREZYME 400 UNIT VIALS. The contract, valued at $7,881.60, has a period of performance through June 25, 2024. DMS Pharmaceutical Group Inc. is registered in the System for Award Management (SAM.gov) and has a significant single-award Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue delivery orders for a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This delivery order is not associated with a set-aside designation.

Generated 1/31/25, 9:17 AM